Reverse shoulder arthroplasty (also known as RSA) was developed in Europe in the late 1980s, in order to treat rotator cuff joint abnormalities in conjunction with degenerative arthritis of the shoulder. Only approved by the FDA in 2004, RSA has significantly improved rotator cuff and arthritis treatments. It has the potential to successfully treat insufficiencies